calendar
3,823 catalysts · 3,291 8k filing · 575 earnings · 172 phase 2 completion · 73 phase 1 completion · 62 phase 2 initiation · 40 phase 1 initiation
next 91 dayslessmore
MonWedFri
3,823 catalysts · 3,291 8k filing · 575 earnings · 172 phase 2 completion · 73 phase 1 completion · 62 phase 2 initiation · 40 phase 1 initiation
Therapy area: Central Nervous System, Non Malignant Disorders. Indication: Benign Tumor, Mastalgia (Breast Pain)
Therapy area: Central Nervous System. Indication: Pain
Items: 5.07, 9.01
Items: 8.01, 9.01
Items: 2.05
Items: 7.01, 8.01, 9.01
Items: 2.02
Items: 1.01, 7.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 1.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 1.01, 7.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 3.02, 9.01
Items: 2.02, 9.01
Items: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Items: 2.02, 7.01
Items: 5.02
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 5.02, 9.01
Items: 8.01
Items: 5.02
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 5.02
Items: 5.02
Items: 8.01
Items: 2.02, 9.01
Items: 1.01
Items: 5.02
Items: 3.01
Items: 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 9.01
Items: 3.01, 7.01, 9.01
Items: 8.01, 9.01
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Therapy area: Oncology. Indication: Hepatocellular Carcinoma, Liver Cancer
Therapy area: Oncology. Indication: Cervical Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Esophageal Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer, Head And Neck Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Hepatocellular Carcinoma, Hypopharyngeal Cancer, Laryngeal Cancer, Malignant Pleural Mesothelioma, Melanoma, Non-Small Cell Lung Carcinoma, Oral Cancer, Oral Cavity (Mouth) Cancer, Oropharyngeal Cancer, Ovarian Cancer, Pancreatic Cancer, Re
Therapy area: Cardiovascular. Indication: Cerebrovascular Disease, Ischemia
Therapy area: Hematological Disorders. Indication: Hemophilia A (Factor VIII Deficiency)
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Metastatic Breast Cancer